Kodiak Sciences is trading at $94.21, down 4.37%, amid broad market and biotech-sector weakness.

  • No clear company-specific announcement explaining the decline surfaced.
  • Kodiak’s major DAYBREAK results were announced September 28, not November 5.
  • Nasdaq and S&P 500 declines were reported during November 5 trading, alongside biotech sector pressure.